These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure. Heywood JT Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281 [TBL] [Abstract][Full Text] [Related]
9. [Calcium antagonists in the treatment of hypertension]. Omae T Nihon Rinsho; 1989 Aug; 47(8):1794-8. PubMed ID: 2585743 [No Abstract] [Full Text] [Related]
10. Termination and suppression of idiopathic left ventricular tachycardia by diltiazem. Lin L; Conti JB; Curtis AB Clin Cardiol; 1997 Oct; 20(10):890-3. PubMed ID: 9377828 [TBL] [Abstract][Full Text] [Related]
11. Treating coexisting cardiovascular and pulmonary disease with calcium antagonists. Berman BA; Ross RN Ann Allergy; 1986 Mar; 56(3):195-200. PubMed ID: 2420238 [No Abstract] [Full Text] [Related]
12. Contact dermatitis caused by diltiazem cream and cross-reactivity with other calcium channel blockers. Forkel S; Baltzer AB; Geier J; Buhl T Contact Dermatitis; 2018 Oct; 79(4):244-246. PubMed ID: 29851108 [No Abstract] [Full Text] [Related]
13. Early treatment with verapamil or diltiazem in patients with acute myocardial infarction: safety and possible beneficial effects. Sage PR; Kiosoglous AJ; Wuttke RD; Horowitz JD Cardiovasc Drugs Ther; 1999 Jul; 13(4):309-13. PubMed ID: 10516866 [TBL] [Abstract][Full Text] [Related]
14. Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy. Doiuchi J; Hamada M; Ochi T; Ito T; Kokubu T Clin Cardiol; 1985 Mar; 8(3):176-9. PubMed ID: 4038927 [TBL] [Abstract][Full Text] [Related]
15. [Are all calcium antagonists alike?]. Bertel O Schweiz Rundsch Med Prax; 1992 Feb; 81(7):164-7. PubMed ID: 1535950 [TBL] [Abstract][Full Text] [Related]
17. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. Braun S; Boyko V; Behar S; Reicher-Reiss H; Laniado S; Kaplinsky E; Goldbourt U J Am Coll Cardiol; 1998 Mar; 31(4):804-8. PubMed ID: 9525550 [TBL] [Abstract][Full Text] [Related]
18. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs. Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675 [TBL] [Abstract][Full Text] [Related]
19. Hyperplastic gingivitis during diltiazem therapy. Giustiniani S; Robustelli della Cuna F; Marieni M Int J Cardiol; 1987 May; 15(2):247-9. PubMed ID: 3583463 [TBL] [Abstract][Full Text] [Related]